COM:CASIPHARMACEUTICALS
CASI Pharmaceuticals
- Stock
Last Close
5.29
22/11 21:00
Market Cap
87.38M
Beta: -
Volume Today
16.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.27M - | 2.95M 29.85% | 1.63M 44.68% | 4.02M 146.55% | 11.01M 173.65% | |||||||
average payables | 453.65K - | 578.54K 27.53% | 819.36K 41.63% | 974.36K 18.92% | 1.58M 61.77% | 1.53M 3.06% | 3.04M 99.00% | 4.39M 44.42% | 4.23M 3.69% | 4.04M 4.49% | 3.86M 4.35% | |
average receivables | 334.65K - | 11.86K 96.46% | 11.86K 0% | 646.50K - | 2.97M 359.24% | 7.22M 143.31% | 11.39M 57.64% | 11.56M 1.47% | ||||
book value per share | 5.72 - | -0.15 102.58% | -1.88 1,170.70% | 3.72 298.28% | 6.27 68.42% | 12.92 106.15% | 7.61 41.10% | 7.38 2.96% | 6.21 15.90% | 3.27 47.39% | 1.81 44.62% | |
capex per share | -0.02 - | -0.16 891.40% | -0.01 95.20% | -0.04 410.48% | -0.15 280.29% | -2.57 1,590.79% | -1.46 43.12% | -1.75 19.75% | -1.14 34.92% | -0.41 63.89% | -0.17 59.21% | |
capex to depreciation | -2.47 - | -9.68 291.64% | -0.37 96.16% | -3.36 804.54% | -7.94 136.24% | -13.03 64.20% | -6.51 50.03% | -9.87 51.50% | -8.54 13.44% | -2.32 72.87% | -0.60 74.15% | |
capex to operating cash flow | 0.01 - | 0.12 789.64% | 0.00 96.05% | 0.04 704.62% | 0.15 293.92% | 0.76 421.77% | 0.60 20.82% | 0.75 23.78% | 0.58 22.66% | 0.27 53.91% | 0.11 57.83% | |
capex to revenue | -19.65 - | -0.53 97.29% | -3.39 - | -1.28 62.39% | -0.51 59.75% | -0.13 74.66% | -0.07 49.19% | |||||
cash per share | 5.79 - | 3.73 35.58% | 1.58 57.62% | 4.85 206.64% | 7.07 45.79% | 10.04 42.05% | 5.65 43.71% | 6.01 6.29% | 3.57 40.61% | 3.76 5.41% | 2.30 38.78% | |
days of inventory on hand | 421.30 - | 52.06 87.64% | 55.43 6.49% | 141.55 155.37% | 389.06 174.85% | |||||||
days payables outstanding | 36.89K - | 51.43K 39.43% | 474.27 - | 140.85 70.30% | 139.20 1.17% | 75.85 45.51% | 108.75 43.38% | |||||
days sales outstanding | 365.00 - | 114.24 - | 111.98 1.99% | 118.61 5.92% | 109.85 7.39% | 109.22 0.57% | ||||||
debt to assets | 0.12 - | 0.25 104.58% | 0.05 78.60% | 0.03 38.25% | 0.01 60.21% | 0.02 62.20% | 0.01 52.84% | 0.02 54.84% | 0.01 10.83% | 0.26 1,766.74% | ||
debt to equity | -3.29 - | -0.24 92.69% | 0.07 129.82% | 0.04 45.80% | 0.01 64.77% | 0.03 120.12% | 0.02 47.45% | 0.03 61.77% | 0.03 17.63% | 0.81 2,593.15% | ||
dividend yield | ||||||||||||
earnings yield | -0.13 - | -0.69 423.83% | -0.23 66.42% | -0.15 36.40% | -0.05 63.39% | -0.08 49.67% | -0.17 115.04% | -0.19 10.74% | -0.35 80.66% | -1.61 365.06% | -0.28 82.54% | |
enterprise value | 28.50M - | 28.75M 0.89% | 27.48M 4.42% | 38.65M 40.63% | 157.93M 308.64% | 258.00M 63.36% | 245.06M 5.01% | 270.06M 10.20% | 72.35M 73.21% | -21.34M 129.50% | 99.81M 567.76% | |
enterprise value over ebitda | -4.98 - | -4.45 10.57% | -3.88 12.88% | -4.14 6.58% | -14.87 259.71% | -10.41 30.02% | -7.80 25.02% | -16.66 113.49% | -2.26 86.44% | 2.80 223.77% | -3.58 227.95% | |
ev to operating cash flow | -8.70 - | -7.20 17.28% | -4.98 30.73% | -6.42 28.73% | -24.67 284.44% | -9.03 63.41% | -10.54 16.81% | -10.43 1.05% | -2.70 74.17% | 1.01 137.54% | -5.00 594.02% | |
ev to sales | 1.21K - | 575.99 52.47% | 59.32 - | 17.84 69.93% | 2.40 86.55% | -0.50 120.64% | 2.95 695.17% | |||||
free cash flow per share | -1.27 - | -1.56 22.83% | -1.71 9.41% | -1.12 34.51% | -1.19 6.68% | -5.94 398.17% | -3.88 34.64% | -4.09 5.40% | -3.11 24.00% | -1.96 37.11% | -1.66 15.04% | |
free cash flow yield | -0.08 - | -0.12 54.23% | -0.18 51.58% | -0.10 45.33% | -0.04 62.25% | -0.15 302.75% | -0.13 14.97% | -0.14 10.40% | -0.39 180.25% | -1.09 181.06% | -0.23 78.76% | |
graham net net | 5.58 - | -0.37 106.55% | -2.09 472.53% | 3.61 272.65% | 6.00 66.34% | 9.58 59.53% | 5.06 47.20% | 4.20 16.97% | 1.95 53.56% | 2.55 30.90% | -0.36 114.05% | |
graham number | 16.81 - | 5.52 67.18% | 9.68 75.50% | 11.90 22.90% | 15.71 32.01% | 30.69 95.36% | 30.28 1.33% | 30.67 1.29% | 19.69 35.81% | 14.57 26.01% | 9.06 37.82% | |
income quality | 0.57 - | 0.15 73.29% | 0.77 401.74% | 0.64 16.72% | 0.59 6.70% | 1.04 75.04% | 0.51 50.76% | 0.54 6.33% | 0.75 37.45% | 0.52 30.05% | 0.74 41.50% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.17 Infinity% | 0.16 0.61% | 0.10 37.18% | 0.09 14.68% | 0.01 87.48% | 0.02 121.19% | |
interest coverage | -3.46K - | 933.13 126.95% | 86.74 90.70% | 278.65 221.24% | -717.90 357.64% | -3.23K 349.80% | 37.66 101.17% | -0.91 - | ||||
interest debt per share | -0.00 - | 0.50 78,243.01% | 0.48 3.83% | 0.27 42.76% | 0.25 9.85% | 0.18 27.71% | 0.12 33.27% | 0.12 1.46% | 0.16 36.05% | 2.22 1,296.16% | 1.47 33.90% | |
inventory turnover | 0.87 - | 7.01 709.34% | 6.58 6.09% | 2.58 60.84% | 0.94 63.62% | |||||||
invested capital | -3.29 - | -0.24 92.69% | 0.07 129.82% | 0.04 45.80% | 0.01 64.77% | 0.03 120.12% | 0.02 47.45% | 0.03 61.77% | 0.03 17.63% | 0.81 2,593.15% | ||
market cap | 43.63M - | 38.03M 12.83% | 31.15M 18.10% | 64.25M 106.27% | 199.92M 211.16% | 340.70M 70.42% | 296.48M 12.98% | 325.83M 9.90% | 108.88M 66.58% | 24.43M 77.56% | 95.66M 291.58% | |
net current asset value | 14.85M - | -710.00K 104.78% | -6.34M 793.58% | 20.52M 423.43% | 37.25M 81.54% | 88.62M 137.89% | 52.53M 40.72% | 49.86M 5.08% | 31.63M 36.57% | 44.12M 39.49% | 8.24M 81.32% | |
net debt to ebitda | 2.64 - | 1.44 45.64% | 0.52 63.99% | 2.74 429.22% | 3.95 44.38% | 3.34 15.63% | 1.64 50.92% | 3.44 110.13% | 1.14 66.85% | 6.00 425.60% | -0.15 102.48% | |
net income per share | -2.20 - | -9.16 317.18% | -2.22 75.76% | -1.69 23.82% | -1.75 3.47% | -3.24 85.13% | -5.36 65.30% | -5.66 5.73% | -2.78 51.01% | -2.89 4.06% | -2.02 30.18% | |
operating cash flow per share | -1.25 - | -1.40 11.44% | -1.70 21.62% | -1.08 36.56% | -1.04 3.46% | -3.37 224.05% | -2.42 28.17% | -2.34 3.25% | -1.97 15.85% | -1.55 21.65% | -1.49 3.28% | |
payables turnover | 0.01 - | 0.01 28.28% | 0.77 - | 2.59 236.72% | 2.62 1.18% | 4.81 83.52% | 3.36 30.25% | |||||
receivables turnover | 1 - | 3.19 - | 3.26 2.03% | 3.08 5.59% | 3.32 7.97% | 3.34 0.57% | ||||||
research and ddevelopement to revenue | 116.55 - | 85.42 26.71% | 2.36 - | 0.76 67.90% | 0.48 36.89% | 0.37 22.38% | 0.26 30.06% | |||||
return on tangible assets | -0.37 - | -2.32 526.11% | -1.24 46.61% | -0.34 72.42% | -0.24 30.00% | -0.29 21.57% | -0.60 106.53% | -0.55 8.89% | -0.30 45.17% | -0.41 38.24% | -0.37 11.41% | |
revenue per share | 0.01 - | 0.01 77.22% | 0.43 - | 1.37 218.39% | 2.22 61.69% | 3.16 42.50% | 2.54 19.72% | |||||
roe | -0.38 - | 62.06 16,260.06% | 1.18 98.09% | -0.45 138.42% | -0.28 38.56% | -0.25 10.19% | -0.70 180.62% | -0.77 8.95% | -0.45 41.75% | -0.88 97.80% | -1.11 26.08% | |
roic | -0.38 - | 27.09 7,147.36% | -1.57 105.78% | 0.42 127.12% | -0.27 163.35% | -0.23 14.27% | -0.59 154.02% | -0.53 9.55% | -0.42 20.97% | -0.59 41.00% | -0.69 17.74% | |
sales general and administrative to revenue | 158.32 - | 65.36 58.72% | 6.62 - | 1.30 80.38% | 0.79 39.33% | 0.54 30.95% | 0.75 37.75% | |||||
shareholders equity per share | 5.72 - | -0.15 102.58% | -1.88 1,170.70% | 3.72 298.28% | 6.27 68.42% | 12.92 106.15% | 7.61 41.10% | 7.38 2.96% | 6.21 15.90% | 3.27 47.39% | 1.81 44.62% | |
stock based compensation to revenue | 92.26 - | 32.30 64.99% | 1.77 - | 0.52 70.81% | 0.26 50.14% | 0.16 36.86% | 0.21 31.00% | |||||
tangible asset value | 14.94M - | -422.21K 102.83% | -6.09M 1,341.80% | 20.78M 441.42% | 38.54M 85.43% | 90.68M 135.28% | 76.77M 15.34% | 90.36M 17.71% | 95.76M 5.97% | 65.87M 31.21% | 22.33M 66.11% | |
tangible book value per share | 5.72 - | -0.15 102.58% | -1.88 1,170.70% | 3.72 298.28% | 6.27 68.42% | 10.70 70.77% | 8.00 25.22% | 8.18 2.25% | 7.04 14.00% | 4.83 31.40% | 1.67 65.38% | |
working capital | 14.85M - | 10.10M 31.95% | 4.52M 55.30% | 26.13M 478.71% | 38.75M 48.28% | 88.69M 128.88% | 53.55M 39.62% | 66.05M 23.33% | 48.78M 26.14% | 56.42M 15.65% | 42.62M 24.46% |
All numbers in (except ratios and percentages)